The three National HIV Curriculum Podcast editors discuss the multiple factors they consider before switching to another oral ART option or to injectable cabotegravir/rilpivirine, including adherence, patient preference, weight gain, NRTI resistance, HBV status, and dosing schedules. View episode transcript at www.hiv.uw.edu (www.hiv.uw.edu/podcast/episode/expert-interviews/switching-art-regimens-discussion) .
This podcast explores practice-changing issues and updates in HIV diagnosis, management, and prevention. The three podcast hosts include Lead Editor Dr. Brian Wood, Associate Professor of Medicine at the University of Washington (UW), Editor Dr. Jehan Budak, UW Assistant Professor of Medicine, and Editor Dr. Aley Kalapila, Associate Professor of Medicine, Emory University School of Medicine, Grady Health System. The hosts are also National HIV Curriculum Associate Editors.